Evaluation of a neural networks QSAR method based on ligand representation using substituent descriptors. Application to HIV-1 protease inhibitors.
暂无分享,去创建一个
[1] Kenneth Levenberg. A METHOD FOR THE SOLUTION OF CERTAIN NON – LINEAR PROBLEMS IN LEAST SQUARES , 1944 .
[2] B. Rost,et al. Improved prediction of protein secondary structure by use of sequence profiles and neural networks. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[3] Ram Samudrala,et al. Rappertk: a versatile engine for discrete restraint-based conformational sampling of macromolecules , 2007, BMC Structural Biology.
[4] Zheng Rong Yang,et al. Reduced bio basis function neural network for identification of protein phosphorylation sites: comparison with pattern recognition algorithms , 2004, Comput. Biol. Chem..
[5] Tarun Khanna,et al. Foundations of neural networks , 1990 .
[6] S H Kim,et al. Prediction of protein folding class from amino acid composition , 1993, Proteins.
[7] D. Zakarya,et al. Structure-toxicity relationships study of a series of organophosphorus insecticides , 2002, Journal of molecular modeling.
[8] Gajendra Pal Singh Raghava,et al. Prediction of β‐turns in proteins from multiple alignment using neural network , 2003, Protein science : a publication of the Protein Society.
[9] Geoffrey E. Hinton,et al. Learning representations by back-propagating errors , 1986, Nature.
[10] Jay W. Ponder,et al. Analysis and Application of Potential Energy Smoothing and Search Methods for Global Optimization , 1998 .
[11] J. Hulten,et al. Synthesis and comparative molecular field analysis (CoMFA) of symmetric and nonsymmetric cyclic sulfamide HIV-1 protease inhibitors. , 2001, Journal of medicinal chemistry.
[12] A. Ghose,et al. Atomic physicochemical parameters for three dimensional structure directed quantitative structure‐activity relationships III: Modeling hydrophobic interactions , 1988 .
[13] D. Marquardt. An Algorithm for Least-Squares Estimation of Nonlinear Parameters , 1963 .
[14] Nikolaj Blom,et al. BIOINFORMATICS APPLICATIONS NOTE Sequence analysis NetAcet: prediction of N-terminal acetylation sites , 2004 .
[15] P A Kollman,et al. Determination of the relative binding free energies of peptide inhibitors to the HIV-1 protease. , 1991, Journal of medicinal chemistry.
[16] D. Connelly,et al. Cross‐validation of protein structural class prediction using statistical clustering and neural networks , 1993, Protein science : a publication of the Protein Society.
[17] S. Rick,et al. Reaction path and free energy calculations of the transition between alternate conformations of HIV‐1 protease , 1998, Proteins.
[18] T Lengauer,et al. The particle concept: placing discrete water molecules during protein‐ligand docking predictions , 1999, Proteins.
[19] Bahram Hemmateenejad,et al. Genetic Algorithm Applied to the Selection of Factors in Principal Component-Artificial Neural Networks: Application to QSAR Study of Calcium Channel Antagonist Activity of 1, 4-Dihydropyridines (Nifedipine Analogous) , 2003, J. Chem. Inf. Comput. Sci..
[20] R. Lohmann,et al. A neural network model for the prediction of membrane‐spanning amino acid sequences , 1994, Protein science : a publication of the Protein Society.
[21] Peter C. Jurs,et al. Development of Quantitative Structure-Activity Relationship and Classification Models for a Set of Carbonic Anhydrase Inhibitors , 2002, J. Chem. Inf. Comput. Sci..
[22] D. Manallack,et al. Analysis of linear and nonlinear QSAR data using neural networks. , 1994, Journal of medicinal chemistry.
[23] Pengyu Y. Ren,et al. Polarizable Atomic Multipole Water Model for Molecular Mechanics Simulation , 2003 .
[24] B. G. Rao,et al. Structural and Kinetic Analyses of the Protease from an Amprenavir-Resistant Human Immunodeficiency Virus Type 1 Mutant Rendered Resistant to Saquinavir and Resensitized to Amprenavir , 2000, Journal of Virology.
[25] Quantitative structure-activity relationships of some HIV-protease inhibitors. , 1999, Journal of enzyme inhibition.
[26] Benny Lautrup,et al. Neural Networks: Computers With Intuition , 1990 .
[27] D. Zakarya,et al. QSAR for anti-HIV activity of HEPT derivatives , 2002, SAR and QSAR in environmental research.
[28] M. Jaskólski,et al. Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease. , 1989, Science.
[29] Ray Luo,et al. Comparison of generalized born and poisson models: Energetics and dynamics of HIV protease , 2000 .
[30] R M Stroud,et al. Domain flexibility in retroviral proteases: structural implications for drug resistant mutations. , 1998, Biochemistry.
[31] Anton J. Hopfinger,et al. Receptor-Independent 4D-QSAR Analysis of a Set of Norstatine Derived Inhibitors of HIV-1 Protease , 2003, J. Chem. Inf. Comput. Sci..
[32] Johannes Schuchhardt,et al. Adaptive encoding neural networks for the recognition of human signal peptide cleavage sites , 2000, Bioinform..
[33] D. Joseph-McCarthy,et al. Automated generation of MCSS‐derived pharmacophoric DOCK site points for searching multiconformation databases , 2003, Proteins.
[34] S. Brunak,et al. Prediction, conservation analysis, and structural characterization of mammalian mucin-type O-glycosylation sites. , 2005, Glycobiology.
[35] Carlo W Boutton,et al. Genotype dependent QSAR for HIV-1 protease inhibition. , 2005, Journal of medicinal chemistry.
[36] David M. Skapura,et al. Building neural networks , 1995 .
[37] G Schneider,et al. Artificial neural networks for computer-based molecular design. , 1998, Progress in biophysics and molecular biology.
[38] G. Schneider,et al. Development of artificial neural filters for pattern recognition in protein sequences , 1993, Journal of Molecular Evolution.
[39] Rajni Garg,et al. A mechanistic study of 3-aminoindazole cyclic urea HIV-1 protease inhibitors using comparative QSAR. , 2004, Bioorganic & medicinal chemistry.
[40] A Wlodawer,et al. Inhibitors of HIV-1 protease: a major success of structure-assisted drug design. , 1998, Annual review of biophysics and biomolecular structure.
[41] P. Lam,et al. Counteracting HIV-1 protease drug resistance: structural analysis of mutant proteases complexed with XV638 and SD146, cyclic urea amides with broad specificities. , 1998, Biochemistry.
[42] A. K. Madan,et al. Superpendentic Index: A Novel Topological Descriptor for Predicting Biological Activity , 1999, J. Chem. Inf. Comput. Sci..
[43] Cathy H. Wu,et al. Motif identification neural design for rapid and sensitive protein family search , 1996, Comput. Appl. Biosci..
[44] Cathy H. Wu,et al. Neural networks and genome informatics , 2000 .
[45] Ajit Narayanan,et al. Mining viral protease data to extract cleavage knowledge , 2002, ISMB.
[46] C. Hutchison,et al. Analysis of retroviral protease cleavage sites reveals two types of cleavage sites and the structural requirements of the P1 amino acid. , 1991, The Journal of biological chemistry.
[47] Klaus L.E. Kaiser,et al. The use of neural networks in QSARs for acute aquatic toxicological endpoints , 2003 .
[48] Konstantin V. Balakin,et al. Structure-Based versus Property-Based Approaches in the Design of G-Protein-Coupled Receptor-Targeted Libraries , 2003, J. Chem. Inf. Comput. Sci..
[49] Richard Dybowski,et al. Clinical applications of artificial neural networks: Theory , 2001 .
[50] Peter C. Jurs,et al. Prediction of Glycine/NMDA Receptor Antagonist Inhibition from Molecular Structure , 2002, J. Chem. Inf. Comput. Sci..
[51] Paolo Carloni,et al. Conformational flexibility of the catalytic Asp dyad in HIV‐1 protease: An ab initio study on the free enzyme , 2000, Proteins.
[52] M. Flonta,et al. Correlation between the predicted and the observed biological activity of the symmetric and nonsymmetric cyclic urea derivatives used as HIV‐1 protease inhibitors. A 3D‐QSAR‐CoMFA method for new antiviral drug design , 2003, Journal of cellular and molecular medicine.
[53] Rajni Garg,et al. HIV-1 protease inhibitors: a comparative QSAR analysis. , 2003, Current medicinal chemistry.
[54] M. Karplus,et al. Genetic neural networks for quantitative structure-activity relationships: improvements and application of benzodiazepine affinity for benzodiazepine/GABAA receptors. , 1996, Journal of medicinal chemistry.
[55] I. Weber,et al. Molecular mechanics analysis of inhibitor binding to HIV-1 protease. , 1992, Protein engineering.
[56] Rajarshi Guha,et al. Development of Linear, Ensemble, and Nonlinear Models for the Prediction and Interpretation of the Biological Activity of a Set of PDGFR Inhibitors , 2004, J. Chem. Inf. Model..
[57] A. Gronenborn,et al. Folded Monomer of HIV-1 Protease* , 2001, The Journal of Biological Chemistry.
[58] O. Lund,et al. novel sequence representations Reliable prediction of T-cell epitopes using neural networks with , 2003 .
[59] M. Shamsipur,et al. Multicomponent acid–base titration by principal component-artificial neural network calibration , 2002 .
[60] Lu Wang,et al. Does a diol cyclic urea inhibitor of HIV-1 protease bind tighter than its corresponding alcohol form? A study by free energy perturbation and continuum electrostatics calculations , 2001, J. Comput. Aided Mol. Des..
[61] S Brunak,et al. Protein structures from distance inequalities. , 1993, Journal of molecular biology.
[62] R. Erb,et al. Introduction to Backpropagation Neural Network Computation , 1993, Pharmaceutical Research.
[63] I. Luque,et al. Molecular basis of resistance to HIV-1 protease inhibition: a plausible hypothesis. , 1998, Biochemistry.
[64] Ted von Hippel,et al. Three-dimensional Spectral Classification of Low-Metallicity Stars Using Artificial Neural Networks , 2001, astro-ph/0107409.
[65] J. Sutherland,et al. A comparison of methods for modeling quantitative structure-activity relationships. , 2004, Journal of medicinal chemistry.
[66] T. Niwa. Prediction of biological targets using probabilistic neural networks and atom-type descriptors. , 2004, Journal of medicinal chemistry.
[67] Anton J. Hopfinger,et al. A Simple Clustering Technique To Improve QSAR Model Selection and Predictivity: Application to a Receptor Independent 4D-QSAR Analysis of Cyclic Urea Derived Inhibitors of HIV-1 Protease , 2003, J. Chem. Inf. Comput. Sci..
[68] M. Navia,et al. Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1 , 1989, Nature.
[69] P. Jadhav,et al. Preparation and structure-activity relationship of novel P1/P1'-substituted cyclic urea-based human immunodeficiency virus type-1 protease inhibitors. , 1996, Journal of medicinal chemistry.
[70] Chong-Hwan Chang,et al. Cyclic HIV protease inhibitors: synthesis, conformational analysis, P2/P2' structure-activity relationship, and molecular recognition of cyclic ureas. , 1996, Journal of medicinal chemistry.
[71] Sorin Draghici,et al. Predicting HIV drug resistance with neural networks , 2003, Bioinform..
[72] Peter C. Jurs,et al. Classification of Inhibitors of Protein Tyrosine Phosphatase 1B Using Molecular Structure Based Descriptors , 2003, J. Chem. Inf. Comput. Sci..
[73] David A Winkler,et al. Neural networks as robust tools in drug lead discovery and development , 2004, Molecular biotechnology.
[74] A. Bax,et al. Long-range magnetization transfer between uncoupled nuclei by dipole-dipole cross-correlated relaxation: a precise probe of beta-sheet geometry in proteins. , 2002, Journal of the American Chemical Society.
[75] Cathy H. Wu,et al. Gene classification artificial neural system , 1995, Proceedings First International Symposium on Intelligence in Neural and Biological Systems. INBS'95.
[76] Carlos E. Padilla,et al. MBO(N)D: A multibody method for long‐time molecular dynamics simulations , 2000 .
[77] J. Topliss,et al. Chance factors in studies of quantitative structure-activity relationships. , 1979, Journal of medicinal chemistry.
[78] Ulf Norinder,et al. Refinement of Catalyst hypotheses using simplex optimisation , 2000, J. Comput. Aided Mol. Des..
[79] M G Ford,et al. Selecting compounds for focused screening using linear discriminant analysis and artificial neural networks. , 2004, Journal of molecular graphics & modelling.
[80] Gordon M. Crippen,et al. Atomic physicochemical parameters for three-dimensional-structure-directed quantitative structure-activity relationships. 2. Modeling dispersive and hydrophobic interactions , 1987, J. Chem. Inf. Comput. Sci..
[81] Johann Gasteiger,et al. Neural Networks for Chemists: An Introduction , 1993 .
[82] S. Miertus,et al. A computational study of the resistance of HIV-1 aspartic protease to the inhibitors ABT-538 and VX-478 and design of new analogues. , 1998, Biochemical and biophysical research communications.
[83] B. Rost. PHD: predicting one-dimensional protein structure by profile-based neural networks. , 1996, Methods in enzymology.
[84] John P. Overington,et al. X-ray analysis of HIV-1 proteinase at 2.7 Å resolution confirms structural homology among retroviral enzymes , 1989, Nature.
[85] Ian Spence,et al. Selective descriptor pruning for QSAR/QSPR studies using artificial neural networks , 2003, J. Comput. Chem..
[86] I. Muchnik,et al. Prediction of protein folding class using global description of amino acid sequence. , 1995, Proceedings of the National Academy of Sciences of the United States of America.